51,644 XNAS Volume
XNAS 04 Apr, 2025 5:30 PM (EDT)
Zentek Ltd Key Metrics
Default
All financials are in CAD Million and price data in USD
VIEW MORE
Not Eligible
Expensive Valuation
Technically Neutral
Check Before You Buy
VIEW FULL CHECKLISTMedium rank
8Positive11Negative
42.1% Pass in checklist
Check P/E Buy Sell Zone
This stock has negative PE
Zentek Ltd Stock Price Analysis
Day Price Range | 1 (LTP) 11.1 LowHigh |
Week Price Range | 1 (LTP) 11.2 LowHigh |
Month Price Range | 1 (LTP) 0.91.2 LowHigh |
52 Week Price Range | 1 (LTP) 0.51.3 LowHigh |
Zentek Ltd Live Price Chart
Switch to TradingView
Fetching data ...
Zentek Ltd Stock Analysis
Zentek Ltd stock analysis with key metrics, changes, and trends.
Zentek Ltd Metric | VALUE | CHANGE % | TREND | ANALYSIS | |
---|---|---|---|---|---|
Annual Revenue | $0.03 M | 59.07% | negative |
| |
Annual Net Profit | $11.7 M | 18.8% | positive |
| |
Price to Earning Ratio | -14.47 | - | negative |
| |
Stock Price | $1.04 | -10.34% | negative |
| |
Quarterly Revenue | $0.04 M | 203.7% | positive |
| |
Quarterly Net profit | $2.6 M | 3.1% | positive |
| |
Debt to Equity Ratio | 0.06 | - | positive |
| |
Return on Equity(ROE) | -46.30 % | -46.3% | negative |
| |
Interest Coverage Ratio | -108.93 | - | negative |
| |
Institutional Holding | 1.61 % | 0.2% | positive |
|
Loading data..
Zentek Ltd - Company Profile
What does Zentek Ltd do?
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.
Zentek Ltd Management structure
All Gross Remunerations are in USD
Zentek Ltd Board of directors
All Gross Remunerations are in USD